secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2021-08-10T23:59:59+00:00
Accession:  0001493152-21-019112
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis Q2 revenue $9.1M (+70% YoY); sees system revenue doubling in 2022
-----------------------------------------------------------------------------

- Revenue up ~70% YoY to $9.1M; system revenue $2.7M, recurring $6.1M.
- Operating loss $3.4M, net loss $1.2M; adjusted net income $1.6M excluding stock comp.
- Cash $44.2M; free cash flow negative $0.1M vs negative $1.2M prior year.
- Received two robotic system orders (U.S. and Beijing); expects ~$11M system revenue in 2021.
- Guidance: system revenue doubling in 2022; magnetic ablation catheter regulatory submissions in early 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000149315221019112/0001493152-21-019112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000149315221019112/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-019112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer